ST. PAUL, Minn. (Jan. 17, 2023) – Intricon, developer and manufacturer of medical devices powered by smart miniaturized electronics, today announced that it has launched a new Biosensors Center of Excellence (CoE). The new CoE combines Intricon’s biosensor device expertise and capabilities into a vertically integrated business unit focused exclusively on bringing Biosensor devices to the medical market.
“OEMs and start-ups need an approach like this because there are important intricacies in
creating medical biosensor devices vs. consumer biosensor products,” said Scott Longval,
Intricon CEO. “There’s a mass movement toward biosensors for medical applications, such as hospital at home and remote patient monitoring. Creating and commercializing first- and next-generation medical biosensor devices are more complex than ever and must happen at scale and cost profile to meet the demands of these exploding use cases.”
Longval adds that Intricon’s intensified focus on biosensors is a natural evolution for the
company, given its more than four decades of experience in wearable medical biosensor devices. Intricon was an early innovator of hearing aids — the precursor to today’s modern body-worn devices — and is the primary developer and manufacturer of wearable glucose monitoring devices for the world’s largest med device company.
“We’re responding to the industry, which needs deep expertise in the many complex capabilities required to successfully compete in this quickly emerging device category,” said Dave Liebl, Intricon chief commercial and technology officer.
The Intricon Biosensor CoE team has deep expertise in high-density microelectronics,
miniaturization, ultra-low power, miniature molding, firmware development, and wireless
communication, including Bluetooth and Bluetooth Low Energy technology. Intricon plans to expand its team of biosensors experts, with key hires in 2023.
Intricon’s other sensor-driven expertise is in developing and manufacturing medical devices that use electromagnetic (EM) navigation. The company has proprietary modeling and engineering systems to design and produce micro-coils that meet electromagnetic goals such as induction, resistance, sensitivity, and localization performance.
For four decades, Intricon has improved and extended people’s lives by developing and
manufacturing sensor-driven micromedical devices. Intricon partners with medical device
companies, providing unique microelectronic expertise — including miniature molding through final assembly – and regulatory guidance, supply chain optimization, and scalable production, exclusively for the medical market. Intricon brings the world’s smallest, smartest new and next generation devices to life.